|
Volumn 11, Issue , 2014, Pages 177-
|
Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDIABETIC AGENT;
CD31 ANTIGEN;
CYTOKINE;
GLUCOSE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;
INTERCELLULAR ADHESION MOLECULE 1;
METFORMIN;
PROTEIN ZO1;
TJP1 PROTEIN, MOUSE;
ANIMAL;
ANOXIA;
BLOOD BRAIN BARRIER;
BRAIN INFARCTION;
CELL CULTURE;
DEFICIENCY;
DISEASE MODEL;
DRUG EFFECTS;
GENE EXPRESSION REGULATION;
INFARCTION, MIDDLE CEREBRAL ARTERY;
MALE;
METABOLISM;
MOUSE;
NEUTROPHIL CHEMOTAXIS;
PATHOLOGY;
SIGNAL TRANSDUCTION;
TIME;
AMP-ACTIVATED PROTEIN KINASES;
ANIMALS;
ANOXIA;
ANTIGENS, CD31;
BLOOD-BRAIN BARRIER;
BRAIN INFARCTION;
CELLS, CULTURED;
CYTOKINES;
DISEASE MODELS, ANIMAL;
GENE EXPRESSION REGULATION;
GLUCOSE;
HYPOGLYCEMIC AGENTS;
INFARCTION, MIDDLE CEREBRAL ARTERY;
INTERCELLULAR ADHESION MOLECULE-1;
MALE;
METFORMIN;
MICE;
NEUTROPHIL INFILTRATION;
SIGNAL TRANSDUCTION;
TIME FACTORS;
ZONULA OCCLUDENS-1 PROTEIN;
|
EID: 84925883213
PISSN: None
EISSN: 17422094
Source Type: Journal
DOI: 10.1186/s12974-014-0177-4 Document Type: Article |
Times cited : (161)
|
References (0)
|